Laxmi Dental Q2 FY26: profit up 45 percent on 25 percent revenue growth

Revenue Growth 20pctPat Growth 25pctNegative Operating CashflowExceptional ItemResults View source PDF Explain this filing

LAXMIDENTL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.7%Reaction day

₹260.00

prior close

₹261.70

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-0.5% vs market

Medical Equipment & Supplies peers, median of 14sector-1.4%+2.1% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 2.1 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

+0.4

15m

+0.2

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.7+1.3-0.5-1.4+2.1

Next day

+1.1+2.6-1.5-0.2+1.3

+2.3+2.7-0.4-0.4+2.7

+1.2+2.1-1.0-0.7+1.8

+0.8+1.6-0.8-2.2+3.0

+3.1+0.8+2.3-3.3+6.4

+4.2+2.2+2.1-3.1+7.3

15d

-5.4-1.6-3.8-8.3+2.9

-9.4-3.0-6.4-8.0-1.4

-24.6-1.6-23.0-10.8-13.8

-32.3-10.5-21.8-21.0-11.3

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 14Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laxmi Dental posted Q2 FY26 consolidated revenue of Rs 746.52M (up 29% YoY) and PAT of Rs 85.32M (up 45% YoY). H1 FY26 PAT was Rs 168.62M versus Rs 227.39M last year, which included a one-time Rs 66.17M property sale gain. Standalone Q2 PAT rose to Rs 65.70M from Rs 37.96M. However, operating cash flow turned negative at Rs (200.07)M for H1. Auditor MSKA and Associates gave an unmodified review opinion.

Likely market impact

Strong Q2 profit growth on robust top-line expansion, but weak operating cash flow and tougher YoY H1 comparison post the prior property sale gain may cap upside.